Seloken 50 mg tablett clinical trials

Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE)

This study looks at how a specific blood pressure medicine, called a beta-blocker (Seloken), affects people with chronic obstructive pulmonary disease (COPD). It checks if the medicine improves health, prevents lung flare-ups, and reduces serious heart problems or strokes, using existing health records.